scholarly journals Single dose pharmacokinetics of intravenous 3,4-dihydroxyphenylacetic acid and 3-hydroxyphenylacetic acid in rats

Fitoterapia ◽  
2020 ◽  
Vol 142 ◽  
pp. 104526
Author(s):  
Volha Zabela ◽  
Chethan Sampath ◽  
Mouhssin Oufir ◽  
Veronika Butterweck ◽  
Matthias Hamburger
2001 ◽  
Vol 183 (3) ◽  
pp. 928-933 ◽  
Author(s):  
Kevin E. O'Connor ◽  
Bernard Witholt ◽  
Wouter Duetz

ABSTRACT Pseudomonas putida F6 was found to metabolizep-hydroxyphenylacetic acid through 3,4-dihydroxyphenylacetic acid, 3,4-dihydroxymandelic acid, and 3,4-dihydroxybenzaldehyde. Cell extracts of P. putida F6 catalyze the NAD(P)H-independent hydroxylation ofp-hydroxyphenylacetic acid to 3,4-dihydroxyphenylacetic acid which is further oxidized to 3,4-dihydroxymandelic acid. Oxidation and decarboxylation of the latter yields 3,4-dihydroxybenzaldehyde. A red-brown color accompanies all of the above enzyme activities and is probably due to the polymerization of quinone-like compounds. 3,4-Dihydroxybenzaldehyde is further metabolized through extradiol ring cleavage.


1979 ◽  
Vol 25 (7) ◽  
pp. 1281-1284 ◽  
Author(s):  
F A Muskiet ◽  
A Groen

Abstract We report quantitative data on beta-glucuronidase- and sulfatase-hydrolyzable conjugates of homovanillic acid, 3,4-dihydroxyphenylacetic acid, p-hydroxyphenylacetic acid, and vanillic acid in the urine of 20 apparently normal and healthy control persons and of three patients with neuroblastoma. We used organic solvent extraction and capillary gas chromatography. There was considerable person-to-person variation in the conjugation percentages calculated. Mean conjugated percentages of the four compounds for 16 normal healthy persons 2.5--40 years of age were, respectively, 12%, 33%, 14%, and 35%. For newborns and patients with neuroblastoma, these percentages were somewhat different. Increased amounts of vanillic acid were found in the urine of the patients with neuroblastoma, but results of a small metabolic study in rats suggest that this increase most probably is of dietary origin.


1977 ◽  
Vol 23 (9) ◽  
pp. 1140-1144 ◽  
Author(s):  
Fumiki Yoshizako ◽  
Mitsuo Chubachi ◽  
Atsuo Nishimura ◽  
Teruo Ueno

Aspergillus fumigatus ATCC 28282 converted phenylacetic acid into a new dihydroxylated compound (2,6-dihydroxyphenylacetic acid) which was identified as 2,6-dimethoxyphenylacetic acid methyl ester. Two other new metabolites have been isolated also and identified as ortho- hydroxyphenylacetic acid and meta-hydroxyphenylacetic acid.


1972 ◽  
Vol 130 (1) ◽  
pp. 141-151 ◽  
Author(s):  
L. A. Griffiths ◽  
G. E. Smith

1. The metabolism of a group of polyphenols related in structure to myricetin (3,5,7,3′,4′,5′-hexahydroxyflavone), including myricetin, myricitrin, 3,4,5-trihydroxyphenylacetic acid, delphinidin, robinetin, tricetin, tricin, malvin and 5,7-dihydroxy-3′,4′,5′-trimethoxyflavone, has been studied both in vivo after oral administration to the rat and in vitro in cultures of micro-organisms derived from the intestine of the rat. 2. It was shown that the rat intestinal microflora are able to degrade compounds of this group to the ring-fission products observed in urine after oral administration of the specific flavonoid. 3. All flavones and flavonols possessing free 5- and 7-hydroxyl groups in the A ring and a free 4′-hydroxyl group in the B ring gave rise to ring-fission products that included 3′,5′-dihydroxyphenylacyl derivatives. 4. The metabolites 3,5-dihydroxyphenylacetic acid, 3-hydroxyphenylacetic acid, 3,5-dihydroxyphenylpropionic acid and 3-hydroxyphenylpropionic acid were isolated and identified by chromatographic and spectral methods. 5. On anaerobic incubation in a thioglycollate medium it was shown that intestinal micro-organisms can effect cleavage of glycosidic bonds, ring fission of certain flavonoid molecules showing 3′,4′,5′-trihydroxyphenyl substitution and dehydroxylation of certain flavonoid metabolites. 6. The urinary excretion of the metabolites 3,5-dihydroxyphenylacetic acid and 3-hydroxyphenylacetic acid was completely abolished when neomycin-treated rats were used.


1967 ◽  
Vol 13 (2) ◽  
pp. 147-157 ◽  
Author(s):  
E. R. Blakley ◽  
W. Kurz ◽  
H. Halvorson ◽  
F. J. Simpson

A Pseudomonas species adapted to grow on phenylacetic acid is simultaneously adapted to the utilization of phenylacetic acid, p-hydroxyphenylacetic acid, and 3,4-dihydroxyphenylacetic acid. Extracts of the organism catalyze the oxidation of p-hydroxyphenylacetic acid and 3,4-dihydroxyphenylacetic acid, but not phenylacetic acid. The addition of NAD or NADH to extracts is required for maximum utilization of p-hydroxyphenylacetic acid; ferrous ion is required for maximum utilization of 3,4-dihydroxyphenylacetic acid. The oxidation of 3,4-dihydroxyphenylacetic acid results in the production of a compound having an absorption maximum at 318 mμ in acid and at 380 mμ in alkali, which was identified as δ-carboxymethyl-α-hydroxymuconic semialdehyde. The degradation of phenylacetic acid by this organism follows a pathway that utilizes p-hydroxyphenylacetic acid and 3,4-dihydroxyphenylacetic acid as intermediates.


Sign in / Sign up

Export Citation Format

Share Document